Contact Us


An osteoid osteoma is a benign bone tumor that almost always presents in children and young adults. These small tumors usually occur in the long bones, most commonly in the femur in the thigh, but can grow in any bone.

Typically, an osteoid osteoma causes localized pain that is worse at night, is unrelated to trauma, and is relieved by treatment with aspirin, ibuprofen, or other non-steroidal anti-inflammatory medications.

Imaging is key to the diagnosis, as the appearance of an osteoid osteoma combined with the clinical symptoms is often diagnostic. Both the radiographic film (Image A below) and the CT scans of the femur (Image B and Image C) in the thigh show the tumor nidus, a dense white calcification in the middle of the tumor. An osteoid osteoma is typically less than one centimeter in diameter, and is surrounded by reactive asymmetric thickening of the bone cortex. The nidus and surrounding bone marrow edema can also be seen using MR imaging (Image D).

Although osteoid osteomas may regress spontaneously over the course of years, current standard of care in patients whose pain is not controlled by medical therapy is a minimally invasive treatment with radiofrequency ablation.

Under CT guidance, a thin drill needle is used to place a cannula into the bone at the tumor focus. The cannula is used to position a radiofrequency electrode, which is then used to heat the tumor to the point that the tumor around the tip of the electrode is coagulated. After radiofrequency ablation, the tumor pain resolves within a few days, and treatment related pain resolves within a few days to a week. Depending on the location of the tumor, weight-bearing activities may be limited for up to 3 months after treatment. The examples below show treatment of osteoid osteomas in the right femur (A) and right tibia (B) with radiofrequency ablation.

The current main alternative treatment approach is surgical resection. After surgery, patients may spend up to a week in the hospital, and may require up to 6 months before they can return to normal activities. Sometimes surgery requires prophylactic placement of internal fixation hardware, if resection of a substantial portion of the surrounding bone leaves the remaining bone weakened.

At Stanford Hospital, experts in MR guided high intensity focused ultrasound (MRgFUS or MRgHIFU) now offer this non-invasive treatment as an alternative to more invasive RF ablation or surgical treatments of osteoid osteoma. The Food and Drug Administration has approved MRgFUS for the treatment of uterine fibroids and of painful bone metastases. Using the same technique as for the treatment of malignant bone cancers, MRgFUS has also been used as a non-invasive method to treat osteoid osteomas. MRgFUS treatment is performed under general, spinal or regional anesthesia in an outpatient setting, allowing the patient to return home in the afternoon after treatment. Compared with radiofrequency ablation, pain relief after MRgFUS is more rapid, occurring within the first day after the procedure. Also, because of the targeted nature of the focused ultrasound therapy, surrounding tissue is undamaged, thus allowing patients to return to normal activities within a week after the treatment.

With MRgFUS treatment, MR imaging is used to identify the nidus of the osteoid osteoma, followed by a single low energy ultrasound treatment that requires 20 seconds to heat the tumor and destroy it. MR imaging is then used to confirm the success of the treatment at the end of the procedure. The images below show an osteoid osteoma in the right tibia, positioned for MRgFUS treatment (A). MR imaging before and after treatment of an osteoid osteoma in the third metacarpal of the hand shows that after the treatment, the tumor lacks vascularity. The Visual Analog Scale pain score has decreased to zero after treatment (B). Images are courtesy of Dr. Alessandro Napoli, La Sapienza University, Rome, Italy.


Contact information:

To make an appointment or a referral, please call 650-736-9081. Referrals can also be faxed to 650-736-7734 or, for Stanford-affiliated physicians, can be entered in Epic.

Last modified Fri, 8 Aug, 2014 at 17:48